HEC Management GP LLC, Director at EAGLE PHARMACEUTICALS, INC. (EGRX), sold 12,918 shares at $60.11 ($776K) on 2019-10-07, disclosed to the SEC on 2019-10-09.
Open-market sale of $776k EGRX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.11 | 4,901 | $295K | 38.0% |
| 2 | $60.11 | 4,901 | $295K | 38.0% |
| 3 | $60.03 | 1,558 | $94K | 12.0% |
| 4 | $60.03 | 1,558 | $94K | 12.0% |
| Total | $60.09 avg | 12,918 | $776K | 100% |
| Filing → |
| USAT | BUY | 2019-09-23 | $639K | — | Filing → |
| EGRX | SELL | 2019-09-13 | $146K | — | Filing → |
| CATM | BUY | 2018-02-23 | $14.9M | — | Filing → |